Advanced in Peripheral T-Cell Lymphoma

Florence Broussais

Pierre-la-treiche, FR 
Advanced in Peripheral T-Cell Lymphoma
Pierre-la-treiche, FR 
OverviewLocationsClinical Research

Overview

Florence Broussais practices in Pierre-la-treiche, France. Ms. Broussais is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Lymphadenitis, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 29 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Peripheral T-Cell Lymphoma.

Gender
Female

Locations

Pierre-la-treiche, France
Other Locations
Lyon, France
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
Enrollment Status: Completed
Publish Date: March 17, 2023
Intervention Type: Drug
Study Drug: Lenalidomide and GA101
Study Phase: Phase 1/Phase 2
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
Enrollment Status: Completed
Publish Date: November 06, 2019
View 1 Less Clinical Trial

29 Total Publications

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.
Journal: HemaSphere
Published: March 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Broussais's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile